Cargando…

Blood eosinophil count predicts treatment failure and hospital readmission for COPD

We examined associations between blood eosinophil counts (BEC) and risk of treatment failure or hospital readmission following acute oral corticosteroid (OCS)-treated COPD exacerbations. We conducted studies from the Optimum Patient Care Research Database (OPCRD) (www.optimumpatientcare.org/opcrd) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerkhof, Marjan, Chaudhry, Isha, Pavord, Ian D., Miravitlles, Marc, Kook Rhee, Chin, Halpin, David M.G., Usmani, Omar S., Jones, Rupert, Kocks, Janwillem, Alacqua, Marianna, Morris, Tamsin, Kaplan, Alan, Price, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927786/ https://www.ncbi.nlm.nih.gov/pubmed/33693048 http://dx.doi.org/10.1183/23120541.00188-2020

Ejemplares similares

Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
por: Chen, Stephanie, et al.
Publicado: (2022)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
por: Price, David B., et al.
Publicado: (2019)

COPD management: role of symptom assessment in routine clinical practice
por: van der Molen, Thys, et al.
Publicado: (2013)

Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths
por: Li, Qing, et al.
Publicado: (2019)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

Relationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD—A Systematic Scoping Review
por: Leving, Marika T., et al.
Publicado: (2022)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
por: Voorham, Jaco, et al.
Publicado: (2019)

Blood eosinophil count as a prognostic biomarker in COPD
por: Oh, Yeon-Mok, et al.
Publicado: (2018)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Hegewald, Matthew J, et al.
Publicado: (2020)

Preventing readmissions of COPD patients: more prospective studies are needed
por: Nuñez, Alexa, et al.
Publicado: (2020)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
por: Pavord, Ian D., et al.
Publicado: (2022)

Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
por: Halpin, David M.G., et al.
Publicado: (2021)

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
por: Kang, Hye Seon, et al.
Publicado: (2021)

Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021)

Variability of blood eosinophil count and prognosis of COPD exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2021)

Diagnosing COPD
por: Halpin, David MG
Publicado: (2006)

Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study
por: Tran, Trung N, et al.
Publicado: (2021)

Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
por: Maetani, Tomoki, et al.
Publicado: (2023)

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
por: Halpin, David M. G., et al.
Publicado: (2016)

Living without eosinophils: evidence from mouse and man
por: Jackson, David J., et al.
Publicado: (2023)

Peripheral eosinophil count and eosinophil-to-lymphocyte ratio are associated with revision sinus surgery
por: Bayer, Karina, et al.
Publicado: (2022)

ABCD of the phosphodiesterase family: interaction and differential activity in COPD
por: Halpin, David MG
Publicado: (2008)

Predicting frequent COPD exacerbations using primary care data
por: Kerkhof, Marjan, et al.
Publicado: (2015)

Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
por: Pavord, Ian D, et al.
Publicado: (2021)

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
por: van Boven, Job FM, et al.
Publicado: (2016)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Identification of COPD Inflammatory Endotypes Using Repeated Sputum Eosinophil Counts
por: Beech, Augusta, et al.
Publicado: (2022)

Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
por: Oscullo, Grace, et al.
Publicado: (2023)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
por: George, Leena, et al.
Publicado: (2019)

Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO(®) Trials
por: Rabe, Klaus F., et al.
Publicado: (2020)

Daytime symptoms of chronic obstructive pulmonary disease: a systematic review
por: Tsiligianni, Ioanna, et al.
Publicado: (2020)

Blood Eosinophil–directed Management of Airway Disease. The Past, Present, and Future
por: Pavord, Ian D.
Publicado: (2020)

Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study)
por: Leving, Marika, et al.
Publicado: (2021)

A potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study
por: Kocks, Janwillem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bmnfem3hclbv260cpqj4j2t80r